Vimta Labs reports 10% YoY growth in Q3 FY26, PAT margins hold at 17.5%
The company reported Q3 total income of Rs. 1,005 million, marking a 10.2% increase year-on-year
The company reported Q3 total income of Rs. 1,005 million, marking a 10.2% increase year-on-year
Pangea will use its integrated validation platform and regulatory expertise to oversee analytical and clinical validation of Gene Solutions’ multi-omics technologies.
Laurus Labs has reported total income of Rs. 1,784.05 crore during the period ended December 31, 2025
The company has posted net profit of Rs. 4,064.9 crore for the 9 months period ended December 31, 2025
Over 8.8?million Indians aged 60 and above currently live with dementia,
The BEAR Implant is the first sports medicine device to carry a label claim related to lowering PTOA risk
The launch of PatroLab is a pivotal milestone, marking a paradigm shift in biologics development and manufacturing
The BD Neopak Glass Prefillable Syringe platform is designed for the complex needs of biologics and combination products
Subscribe To Our Newsletter & Stay Updated